(Q34771228)

4 August 2017

title

Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer (English)

1 reference

4 August 2017

main subject

phase II clinical trial

0 references

1 reference

1 reference

Han Jo Kim

1

1 reference

4 August 2017

Kyoung Ha Kim

2

1 reference

4 August 2017

Jina Yun

3

1 reference

4 August 2017

Se Hyung Kim

4

1 reference

4 August 2017

Hyun Jung Kim

5

1 reference

4 August 2017

Sang-Cheol Lee

6

1 reference

4 August 2017

Sang Byung Bae

7

1 reference

4 August 2017

Chan Kyu Kim

8

1 reference

4 August 2017

Nam Su Lee

9

1 reference

4 August 2017

Kyu Taek Lee

10

1 reference

4 August 2017

Do-Jin Kim

11

1 reference

4 August 2017

Seong-Kyu Park

12

1 reference

4 August 2017

Jong-Ho Won

13

1 reference

4 August 2017

Dae Sik Hong

14

1 reference

4 August 2017

Hee Sook Park

15

1 reference

4 August 2017

publication date

31 March 2011

1 reference

Cancer Research and Treatment

4 August 2017

published in

1 reference

4 August 2017

volume

43

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

19-23

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

4 August 2017

copyright license

start time

31 March 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072531

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072531

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072531

Dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072531

Toxicity and response criteria of the Eastern Cooperative Oncology Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072531

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3072531

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21509159

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21509159

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21509159

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4143/CRT.2011.43.1.19

1 reference

4 August 2017

1 reference

4 August 2017

1 reference